Literature DB >> 20228176

Risk factors for high dialysate glucose use in PD patients--a retrospective 5-year cohort study.

Hon-Yen Wu1, Kuan-Yu Hung, Fu-Chang Hu, Yung-Ming Chen, Tzong-Shinn Chu, Jenq-Wen Huang, Kwan-Dun Wu, Tun-Jun Tsai.   

Abstract

BACKGROUND: Use of high concentrations of glucose for peritoneal dialysis (PD) may produce unfavorable results. Our previous study showed that high initial glucose load is associated with poor PD technique survival.
OBJECTIVE: This retrospective cohort study at a medical center in Taiwan aimed to understand the factors associated with high glucose load in long-term PD patients. PATIENTS AND METHODS: We reviewed 90 newly started PD patients over 5 years. We determined glucose load by calculating annual glucose weight and dialysate volume administered. Multiple linear regression analyses with time-dependent covariates were used to determine factors that influence the annual average dialysate glucose concentration.
RESULTS: The study group included 47 men and 43 women with a mean age of 53.4 +/- 13.9 years. Technique survival rates were 91.0%, 84.1%, and 77.6% at the beginning of the second, third, and fourth year of PD therapy respectively. The presence of diabetes mellitus (DM), high body mass index (BMI), and low weekly renal Kt/V were significantly correlated with high average dialysate glucose concentration during the first, second, and third years. For patients undergoing PD for more than 3 years, residual renal function (RRF) deteriorated, and only DM significantly affected higher dialysate glucose concentration in the fourth year.
CONCLUSIONS: Patients with DM, high BMI, and low RRF were more likely to require a high glucose load for PD therapy, especially during the first 3 years. After those 3 years of PD, DM was the only significant factor in the need for higher glucose load. To reduce the glucose load in chronic PD patients, alternative osmotic agents such as icodextrin or amino acids should be considered in the daily PD regimen.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20228176     DOI: 10.3747/pdi.2009.00063

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  11 in total

1.  Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.

Authors:  Ivana Mikolasevic; Sandra Milic; Sanjin Racki; Luka Zaputovic; Davor Stimac; Mladen Radic; Dean Markic; Lidija Orlic
Journal:  Perit Dial Int       Date:  2015-10-16       Impact factor: 1.756

2.  Peri-aortic fat tissue thickness in peritoneal dialysis patients.

Authors:  Kultigin Turkmen; Orhan Ozbek; Mehmet Kayrak; Cigdem Samur; Ibrahim Guler; Halil Zeki Tonbul
Journal:  Perit Dial Int       Date:  2012-07-01       Impact factor: 1.756

3.  High glucose concentrations in peritoneal dialysate are associated with all-cause and cardiovascular disease mortality in continuous ambulatory peritoneal dialysis patients.

Authors:  Yueqiang Wen; Qunying Guo; Xiao Yang; Xianfeng Wu; Shaozhen Feng; Jiaqing Tan; Ricong Xu; Xueqing Yu
Journal:  Perit Dial Int       Date:  2013-12-01       Impact factor: 1.756

4.  Peritoneal dialysis in diabetics: there is room for more.

Authors:  P Cotovio; A Rocha; A Rodrigues
Journal:  Int J Nephrol       Date:  2011-10-16

5.  Safety issues of long-term glucose load in patients on peritoneal dialysis--a 7-year cohort study.

Authors:  Hon-Yen Wu; Kuan-Yu Hung; Tao-Min Huang; Fu-Chang Hu; Yu-Sen Peng; Jenq-Wen Huang; Shuei-Liong Lin; Yung-Ming Chen; Tzong-Shinn Chu; Tun-Jun Tsai; Kwan-Dun Wu
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

6.  Evaluation of the causes affecting the development of pruritus in patients with peritoneal dialysis.

Authors:  Sumeyra Koyuncu; Eda Oksum Solak; Cigdem Karakukcu; Ali Gundogdu; Cihan Uysal; Gökmen Zararsız; Ismail Kocyigit; Murat Hayri Sipahioğlu; Oktay Oymak; Murat Borlu; Bulent Tokgoz
Journal:  Int Urol Nephrol       Date:  2021-07-02       Impact factor: 2.370

7.  Metabolic syndrome and abdominal fat are associated with inflammation, but not with clinical outcomes, in peritoneal dialysis patients.

Authors:  Jenq-Wen Huang; Chung-Yi Yang; Hon-Yen Wu; Kao-Lang Liu; Chi-Ting Su; Cho-Kai Wu; Jen-Kuang Lee; Chih-Kang Chiang; Hui-Teng Cheng; Yu-Chung Lien; Kuan-Yu Hung
Journal:  Cardiovasc Diabetol       Date:  2013-06-08       Impact factor: 9.951

8.  Glycosylated hemoglobin and albumin-corrected fructosamine are good indicators for glycemic control in peritoneal dialysis patients.

Authors:  Szu-Ying Lee; Yin-Cheng Chen; I-Chieh Tsai; Chung-Jen Yen; Shu-Neng Chueh; Hsueh-Fang Chuang; Hon-Yen Wu; Chih-Kang Chiang; Hui-Teng Cheng; Kuan-Yu Hung; Jenq-Wen Huang
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

9.  High peritoneal KT/V and peritonitis rates are associated with peritoneal calcification.

Authors:  Jenq-Wen Huang; Yu-Chung Lien; Chung-Yi Yang; Kao-Lang Liu; Cheng-Chung Fang; Cho-Kai Wu; Jen-Kuang Lee; Hon-Yen Wu; Chih-Kang Chiang; Hui-Teng Cheng; Chung-Jen Yen; Kuan-Yu Hung
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

10.  Visceral fat area is associated with HbA1c but not dialysate-related glucose load in nondiabetic PD patients.

Authors:  Li-chun Ho; Chung-Jen Yen; Chia-Ter Chao; Chih-Kang Chiang; Jenq-Wen Huang; Kuan-Yu Hung
Journal:  Sci Rep       Date:  2015-08-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.